Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 3144 is a short, non-coding RNA that modulates gene expression post-transcriptionally. It is involved in cell regulation pathways and, through RNA editing, is implicated in liver cancer cell proliferation and differentiation. No targeted therapies currently exist; its role as a biomarker and therapeutic target is under preclinical investigation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 3144 (miR-3144).